Proteomic signatures reveal a dualistic and clinically relevant classification of anal canal carcinoma

MLA

Michael Herfs, et al. “Proteomic Signatures Reveal a Dualistic and Clinically Relevant Classification of Anal Canal Carcinoma.” The Journal of Pathology, vol. 241, Jan. 2017, pp. 522–33. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........1a10477a1a6e8c44caa90a5afa53e0dc&authtype=sso&custid=ns315887.

APA

Michael Herfs, Fabiola Obregon, Patrick Roncarati, Edwin De Pauw, Alizée Lebeau, Christopher P. Crum, Rémi Longuespée, Andrew Dunn, Philippe Delvenne, Meggy Suarez-Carmona, Pascale Hubert, Diane Bruyère, Dominique Baiwir, Charles M. Quick, Nicolas Smargiasso, Eric J Yang, Keith Lai, & Gabriel Mazzucchelli. (2017). Proteomic signatures reveal a dualistic and clinically relevant classification of anal canal carcinoma. The Journal of Pathology, 241, 522–533.

Chicago

Michael Herfs, Fabiola Obregon, Patrick Roncarati, Edwin De Pauw, Alizée Lebeau, Christopher P. Crum, Rémi Longuespée, et al. 2017. “Proteomic Signatures Reveal a Dualistic and Clinically Relevant Classification of Anal Canal Carcinoma.” The Journal of Pathology 241 (January): 522–33. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........1a10477a1a6e8c44caa90a5afa53e0dc&authtype=sso&custid=ns315887.